Summary
Latest filing:
Michael J. Glennon is Director of PAVmed Inc. (PAVM). 2 SEC Form 4 filings on record going back to 2025, most recently on 3 April 2026.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by Michael J. Glennon.
Trading pattern
InsiderAlpha's records for Michael J. Glennon go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Michael J. Glennon's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Stephen M. Bloch - $125.05M in LQDA purchases and sales in the last 12 months
- Jason P. Rhodes - $124.92M in DYN purchases and sales in the last 12 months
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael J. Glennon?
Michael J. Glennon is a corporate insider, tracked as Director of PAVmed Inc. (PAVM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael J. Glennon last file a Form 4?
The most recent primary Form 4 on record is dated 3 April 2026, one of 2 filings going back to 2025.